426 related articles for article (PubMed ID: 20047505)
1. Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease.
Joos GF
Expert Opin Investig Drugs; 2010 Feb; 19(2):257-64. PubMed ID: 20047505
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs.
Casarosa P; Bouyssou T; Germeyer S; Schnapp A; Gantner F; Pieper M
J Pharmacol Exp Ther; 2009 Aug; 330(2):660-8. PubMed ID: 19478135
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in COPD disease management with fixed-dose long-acting combination therapies.
Bateman ED; Mahler DA; Vogelmeier CF; Wedzicha JA; Patalano F; Banerji D
Expert Rev Respir Med; 2014 Jun; 8(3):357-79. PubMed ID: 24802656
[TBL] [Abstract][Full Text] [Related]
4. The scientific rationale for combining long-acting beta2-agonists and muscarinic antagonists in COPD.
Cazzola M; Molimard M
Pulm Pharmacol Ther; 2010 Aug; 23(4):257-67. PubMed ID: 20381630
[TBL] [Abstract][Full Text] [Related]
5. The potential for aclidinium bromide, a new anticholinergic, in the management of chronic obstructive pulmonary disease.
Maltais F; Milot J
Ther Adv Respir Dis; 2012 Dec; 6(6):345-61. PubMed ID: 23075544
[TBL] [Abstract][Full Text] [Related]
6. Inhaled muscarinic acetylcholine receptor antagonists for treatment of COPD.
Montuschi P; Macagno F; Valente S; Fuso L
Curr Med Chem; 2013; 20(12):1464-76. PubMed ID: 22963553
[TBL] [Abstract][Full Text] [Related]
7. NVA237, a long-acting muscarinic antagonist, as an emerging therapy for chronic obstructive pulmonary disease.
Vogelmeier C; Banerji D
Ther Adv Respir Dis; 2011 Jun; 5(3):163-73. PubMed ID: 21511677
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness of Long-Acting Beta
Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405
[TBL] [Abstract][Full Text] [Related]
9. Bronchodilating drugs for chronic obstructive pulmonary disease: current status and future trends.
Montuschi P; Ciabattoni G
J Med Chem; 2015 May; 58(10):4131-64. PubMed ID: 25587755
[TBL] [Abstract][Full Text] [Related]
10. Aclidinium bromide, a novel long-acting muscarinic M3 antagonist for the treatment of COPD.
Cazzola M
Curr Opin Investig Drugs; 2009 May; 10(5):482-90. PubMed ID: 19431081
[TBL] [Abstract][Full Text] [Related]
11. Comparative Cardiovascular and Cerebrovascular Safety of Inhaled Long-Acting Bronchodilators in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.
Dong YH; Chang CH; Gagne JJ; Hsu CL; Lai MS
Pharmacotherapy; 2016 Jan; 36(1):26-37. PubMed ID: 26799347
[TBL] [Abstract][Full Text] [Related]
12. Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease.
ZuWallack AR; ZuWallack RL
Expert Opin Pharmacother; 2004 Aug; 5(8):1827-35. PubMed ID: 15264997
[TBL] [Abstract][Full Text] [Related]
13. Long acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs.
Mastrodicasa MA; Droege CA; Mulhall AM; Ernst NE; Panos RJ; Zafar MA
Expert Opin Investig Drugs; 2017 Feb; 26(2):161-174. PubMed ID: 28004591
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
15. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
Ohar JA; Donohue JF
Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
[TBL] [Abstract][Full Text] [Related]
16. Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?
Salama RO; Young PM; Rogueda P; Lallement A; Iliev I; Traini D
Expert Opin Pharmacother; 2011 Aug; 12(12):1913-32. PubMed ID: 21714776
[TBL] [Abstract][Full Text] [Related]
17. The discovery and development of aclidinium bromide for the treatment of chronic obstructive pulmonary disease.
Malerba M; Radaeli A; Santini G; Morjaria J; Mores N; Mondino C; Macis G; Montuschi P
Expert Opin Drug Discov; 2018 Jun; 13(6):563-577. PubMed ID: 29616842
[TBL] [Abstract][Full Text] [Related]
18. [Glycopyrronium bromide is a long-acting inhaled anticholinergic in the treatment of severe COPD].
Ulrik CS
Ugeskr Laeger; 2013 Aug; 175(35):1946-8. PubMed ID: 23978116
[TBL] [Abstract][Full Text] [Related]
19. Aclidinium bromide and formoterol fumarate for the maintenance treatment of chronic obstructive pulmonary disease.
Haley R; Gupta N; Sethi S
Expert Rev Clin Pharmacol; 2020 Feb; 13(2):103-113. PubMed ID: 31951778
[No Abstract] [Full Text] [Related]
20. Aclidinium bromide for the treatment of chronic obstructive pulmonary disease.
Cazzola M; Page CP; Matera MG
Expert Opin Pharmacother; 2013 Jun; 14(9):1205-14. PubMed ID: 23566013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
